Blood test may predict breast Cancer's return
NCT ID NCT06418126
Summary
This study aims to find a way to predict which patients with triple-negative breast cancer are most likely to have their cancer return after treatment. Researchers will check the blood of 15 patients during their radiation therapy, looking for specific signals (cytokines) that might indicate a higher risk. The goal is to identify patients who need closer monitoring or different treatments in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut de cancérologie Strasbourg europe
Strasbourg, 67033, France
Conditions
Explore the condition pages connected to this study.